drugset / Trial / NCT01837680

Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy

NCT01837680

Completed 105 enrolled St. Luke's-Roosevelt Hospital Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to compare glycemic control in pregnant women treated with insulin Detemir and pregnant women treated with NPH insulin. These women are diagnosed with gestational diabetes (GDM) in the current pregnancy or have a preexisting diagnosis of type 2 diabetes (T2DM) at the onset of pregnancy. Our hypothesis is that there is no difference between these two treatment modalities in terms of glycemic control in diabetes.

Timeline

Start
2013-03
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin detemir Protein / enzyme biologic
Subject insulin neutral protamine Hagedorn Unknown